FDA Clears First Blood Test for Alzheimer’s Disease Diagnosis
The US Food and Drug Administration (FDA) has approved the first blood test to diagnose Alzheimer’s disease, paving the way for earlier detection and treatment of this neurological condition. Developed by Fujirebio, the test is a more affordable alternative to PET scans or spinal taps currently used for diagnosis. Alzheimer’s affects over 7 million Americans … Read more